Meningitis is an inflammation (swelling) of the defensive layers
called meninges covering the brain and spinal cord. A bacterial or viral
contamination of the fluid encompassing the brain and spinal cord ordinarily
causes the swelling. However, wounds, disease, certain medications, and
different kinds of infections can also cause meningitis. Bacterial meningitis
is intense and can be mortal. Additionally, bacterial meningitis can cause
permanent disabilities such as brain damage and hearing loss, if untreated.
However, the vast majority of meningitis can prevent with proper vaccination.
Streptococcus pneumonia, neisseria meningitides, and listeria monocytogenes are
some classes of bacteria that cause meningitis. Nausea, vomiting, photophobia,
and altered mental status are some symptoms of meningitis. Immunization can
help to prevent bacterial meningitis.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40682
Based on vaccine type, the global
meningitis vaccine market can be segmented into haemophilus influenza type
b vaccine, pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine,
meningococcal vaccine, and others. The meningococcal vaccine segment is likely
to expand at a significant pace during the forecast period because
meningococcal vaccine can protect from four classes of bacteria that cause
meningitis. The meningococcal vaccine segment can be sub-classified into
meningococcal conjugate vaccines and serogroup B meningococcal vaccines. In
terms of end-user, meningitis vaccine market can be bifurcated into adults and
children. The children segment is expected to grow at a faster rate because
bacterial meningitis mostly affects children. In terms of distribution channel,
the global meningitis vaccine market can be segmented into hospital pharmacies,
retail pharmacies, and others. The hospital pharmacies segment is likely to
expand at a significant pace during the forecast period as several types of
vaccine are widely available in hospital pharmacies.
Request COVID Analysis on Meningitis
Vaccine Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=40682
Increase in incidence of meningitis in children is one of the
major factors fueling the global meningitis vaccine market. Moreover, risk of
permanent disabilities among children and rise in awareness about proper dose
of immunization is projected to drive the meningitis vaccine market. However,
bacterial resistance to penicillin and lack of access to vaccine approval are
likely to hamper meningitis vaccine market in the next few years.
In terms
of region, the global meningitis vaccine market can be segmented into North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominates the global meningitis vaccine market. The region is
projected to account for a significant share of the global meningitis vaccine
market during the forecast period due to presence of key vaccine manufacturers
and awareness about immunization. Favorable government support in terms of
inclusion of vaccination such as meningococcal C conjugate (MCC) vaccine in
national routine immunization schedules by the European Center for Disease
Prevention and Control to treat meningitis is likely to drive the meningitis
vaccine market in Europe. Incidence of bacterial meningitis is increasing in
countries such as Thailand and North Korea. This drives demand for vaccination
to combat the disease which in turn is expected to propel meningitis vaccine
market in Asia Pacific. Increase in awareness about meningitis immunization and
high prevalence of bacterial meningitis are likely to augment the meningitis
vaccine market in Middle East & Africa during the forecast period.
Pre Book Meningitis Vaccine Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=40682<ype=S
Key players operating in the global meningitis vaccine market
are GlaxoSmithKline, plc, Pfizer, Inc., Merck & Co., Inc., Sanofi Pasteur
SA, Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson
& Johnson, MedImmune, LLC, Serum Institute of India Pvt. Ltd., Bavarian
Nordic, Mitsubishi Tanabe Pharma Corporation, Protein Sciences Corporation, and
Panacea Biotec, among others.
About Us
Transparency Market Research is a global market intelligence company providing
global business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insight
for several decision makers. Our experienced team of analysts, researchers, and
consultants uses proprietary data sources and various tools and techniques to
gather and analyze information.
Our data repository is continuously updated and revised by a team of research
experts so that it always reflects latest trends and information. With a broad
research and analysis capability, Transparency Market Research employs rigorous
primary and secondary research techniques in developing distinctive data sets
and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
